Company Profile

Company Profile


U&G Biotechnology (Hangzhou) Co., Ltd. established in 2020, is a high-tech enterprise specializing in the field of molecular diagnostics, integrating R&D, manufacturing, and sales under one umbrella. Leveraging its independently built innovative biotechnology R&D center and a robust team of experts, U&G Bio is dedicated to delivering premium-quality core materials, cutting-edge innovative solutions, and customized services to the life science research and in vitro diagnostic (IVD) industries. Upholding the customer-first service philosophy and committed to the product goals of "ultra-pure quality and exceptional innovation," the company continuously strives to enhance product excellence.

Core Products and Services


The company specializes in the R&D and production of core raw materials for in vitro diagnostics, and offers services such as custom enzyme sourcing, OEM manufacturing, and process optimization tailored to in vitro diagnostic reagent manufacturers.

 

Company's main product lines include nucleic acid extraction and purification, reverse transcription, PCR, qPCR, NGS, molecular cloning, in vitro transcription, protein research, and cell biology—catering to a wide range of applications in areas such as life science research, next-generation sequencing, diagnostic testing, and biopharmaceuticals.

Core Products and Services
Rooted in China, serving the world

Rooted in China, serving the world


Rooted in the biopharmaceutical ecosystem of Hangzhou Pharmaceutical Harbor Town, UJ Biotech brings together top talent and remains committed to sustained investment in R&D and innovation. We are dedicated to providing the highest-quality, most reliable products and services to life science researchers, in vitro diagnostic companies, and cutting-edge research institutions—both across China and around the globe—working hand-in-hand to advance and expand the adoption of molecular diagnostics technology, ultimately contributing to the global cause of human health.

Corporate Philosophy

Provide customers with ultra-pure, stable, and high-performance enzyme products, as well as specialized customized services.

Corporate Mission

Explore life sciences, protect human health.

Corporate Values

Customer first, deliver on promises, be open and honest, and work together in unity.

Corporate Philosophy

Honorary Qualifications


1

This is placeholder text

2

This is placeholder text

3

This is placeholder text

4

This is placeholder text

Development Journey


Walking Together Toward a Shared Future · Putting Actions into Practice for Lasting Success

2025

• Established a molecular cloning product line, launching high-fidelity enzymes, homologous recombination kits, restriction enzymes, TA cloning products, and more.
• Development and scale-up of multiplex PCR and digital PCR products.
• Enhanced product line for nucleic acid extraction and protein biology applications.

2024

• Research and development, followed by transfer to production, of mRNA vaccine-related products and lyophilizable formulations.
• Established a product line for nucleic acid extraction and protein biology, expanding the range of animal disease detection products.
• Obtained High-Tech Enterprise Certification.

2023

• Thermostable amplification product launched.
• Established a stable collaboration with the Institute of Basic Medical Sciences and Oncology at the Chinese Academy of Sciences.
• First-time certification under both ISO 9001 and ISO 13485 standards.

2022

• Launching animal disease test kits for the first time.
• Established multiple molecular biology product lines, launching related products such as PCR, qPCR, and RT-qPCR.

2021

• Boosting molecular biology products—official website now live!
• Received the third batch of provincial-level recognition as a science and technology-based SME in Hangzhou for 2021.

2020

U&G Biotechnology (Hangzhou) Co., Ltd. was founded in Hangzhou Pharmaceutical Harbor Town and, in the same year, completed the screening and optimization of 32 types of tool enzymes, followed by pilot-scale production and the development of associated reagents.

Development Journey


Walking Together Toward a Shared Future · Putting Actions into Practice for Lasting Success

Development Journey

Founded

2020

2025

• Established a molecular cloning product line, launching high-fidelity enzymes, homologous recombination kits, restriction enzymes, TA cloning products, and more.
• Development and scale-up of multiplex PCR and digital PCR products.
• Enhanced product line for nucleic acid extraction and protein biology applications.

2024

• Research and development, followed by transfer to production, of mRNA vaccine-related products and lyophilizable formulations.
• Established a product line for nucleic acid extraction and protein biology, expanding the range of animal disease detection products.
• Obtained High-Tech Enterprise Certification.

2023

• Thermostable amplification product launched.
• Established a stable collaboration with the Institute of Basic Medical Sciences and Oncology at the Chinese Academy of Sciences.
• First-time certification under both ISO 9001 and ISO 13485 standards.

2022

• Launching animal disease test kits for the first time.
• Established multiple molecular biology product lines, launching related products such as PCR, qPCR, and RT-qPCR.

2021

• Boosting molecular biology products—official website now live!
• Received the third batch of provincial-level recognition as a science and technology-based SME in Hangzhou for 2021.

2020

U&G Biotechnology (Hangzhou) Co., Ltd. was founded in Hangzhou Pharmaceutical Harbor Town and, in the same year, completed the screening and optimization of 32 types of tool enzymes, followed by pilot-scale production and the development of associated reagents.